Board to Vote Later on Allowing Medical Marijuana for Opiate Withdrawal

The board recommended adding brittle bone disease to the program.

The board that votes on which medical conditions medical marijuana can be used to treat in Connecticut decided that the drug could be used in the case of brittle bone disease, but decided to vote later on whether to allow people with opioid use disorder or those going through opiate withdrawal to use medical marijuana.

The Board of Physicians met Monday to vote on whether to include the conditions of albinism, opioid use disorder and opiate withdrawal, osteogenesis imperfecta and progressive degenerative disc disease of the spine.

The board recommended allowing patients with osteogenesis imperfecta, a genetic disorder more commonly known as brittle bone disease, to use medical marijuana.

People who suffer from the condition can break bones easily in the event of mild trauma and even when there is no apparent cause.

The board did not recommend medical marijuana for albinism (Nystagmus) and it tabled voting on opioid use disorder and opiate withdrawal and progressive degenerative disc disease of the spine.

“We want to thank the members of the public including patients and medical professionals who came to share their stories and expertise on Monday,” Consumer Protection Commissioner Michelle Seagull said in a statement. “We value the thoughtful input from the Board of Physicians as we grow this program to support more severely ill patients in the state.”

The Office of the Attorney General must review the recommendations and the regulations review committee of the General Assembly must approve them.

Contact Us